知镜 Cognispect · 医学文献与研究工作台

Multimodal Detection of Subclinical Cardiovascular Disease in Chronic Kidney Disease.

Baek I, Parwani P, Gaznabi S, Abramov D, Alani A.
Cardiorenal medicine · 2026-08-31 · PMID 42671943

文献摘要

Background Cardiovascular disease (CVD) is the leading cause of mortality among individuals with chronic kidney disease (CKD) and is driven by chronic inflammation, oxidative stress, vascular calcification, accumulation of uremic toxins, ventricular remodeling, and microvascular dysfunction. Subclinical CVD is highly prevalent in CKD and often remains unrecognized until advanced stages, contributing to delayed intervention and increased mortality. Summary Early detection of subclinical CVD in CKD is critical to prevent disease progression and reduce adverse outcomes. Advances in noninvasive imaging modalities - including echocardiography, coronary computed tomography angiography, coronary artery calcium (CAC) scoring, and cardiac magnetic resonance imaging - enable sensitive identification of early cardiac and vascular abnormalities. In parallel, circulating and urinary biomarkers such as C-reactive protein, high-sensitivity troponin (hsT), N-terminal pro-brain natriuretic peptide, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), fibroblast growth factor-23, and urine albumin-to-creatinine ratio provide insight into underlying pathophysiological mechanisms and support risk stratification and personalized management. Key messages Subclinical CVD is common yet underdiagnosed in CKD, necessitating improved screening strategies. Integration of advanced imaging techniques with biomarker profiling offers a promising approach for early detection and individualized care. Continued innovation and implementation of these tools are essential to closing the cardiovascular mortality gap in this high-risk population.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。